Skip to main content
. 2014 Jan 22;2014:342986. doi: 10.1155/2014/342986

Table 2.

Clinical response.

Response Imatinib + BSC
(n = 14)
BSC alone
(n = 12)
Responder* 3 1
Nonresponder 6 4
Not evaluable 5 7

BSC: best supportive care.

*Observed clinical response by Choi criteria.

No observed clinical response by Choi criteria.